Ligand Pharmaceuticals Inc director Jason Aryeh trims stake with $960,141 sale
The director sold at an average of $320.05 a share, according to a Form 4 filed with the SEC on Nov 12.
A Form 4 filed on Nov 12 shows Jason Aryeh (Director) selling 3,000 Ligand Pharmaceuticals Inc shares worth about $960,000 on Nov 10.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The trade was reported within two business days, as Section 16 requires.
The insider still holds 105,476 shares after the sale, 2.8% fewer than before. It is the seventh insider sale at Ligand Pharmaceuticals Inc reported in the last 90 days.
Details from the SEC filing:
| Company | Ligand Pharmaceuticals Inc (LGND) |
|---|---|
| Insider | Jason Aryeh |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 3,000 |
| Average price | $320.05 |
| Value | $960,141 |
| Trade date | Nov 10, 2026 |
| Filed with the SEC | Nov 12, 2026, 4:49 PM ET |
| Shares held after | 105,476 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
Read the daily insider trading roundup · Follow LGND for the next insider trade
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.